# Adeshwar Medite (NSE: ADESHWAR) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/ADESHWAR · Pivot · prices to 22 Oct 2026

With a market capitalisation of ₹21 Cr, it ranks 3567th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Medical Instruments & Supplies.

Its return on equity was 5.6% in FY25. Promoters held 57.68% of the company as of 31 Mar 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Market cap | ₹21 Cr |
| ROE | 5.6% (FY25) |
| ROCE | 10.5% (FY25) |
| Debt to equity | 0.34 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹84 Cr | ₹2 Cr |
| FY24 | ₹80 Cr | ₹2 Cr |
| FY23 | ₹82 Cr | ₹2 Cr |
| FY22 | ₹65 Cr | ₹1 Cr |
| FY21 | ₹66 Cr | ₹2 Cr |
| FY20 | ₹56 Cr | ₹2 Cr |

## Shareholding (31 Mar 2026)

- Promoters: 57.68%
- Non-institutions: 42.32%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Transgene Biote](https://app.pivotnow.in/stock/TRABI) | — | ₹23 Cr | — | — |
| [Hamps Bio](https://app.pivotnow.in/stock/HAMPS) | — | ₹22 Cr | — | — |
| [Rekvina Labs](https://app.pivotnow.in/stock/VINRKLB) | — | ₹22 Cr | — | — |
| [Maitri](https://app.pivotnow.in/stock/MAITRI) | — | ₹19 Cr | — | — |
| [Desh Rakshak](https://app.pivotnow.in/stock/DESHRAK) | — | ₹19 Cr | — | — |
| [Nidan Lab](https://app.pivotnow.in/stock/NIDAN) | ₹12.65 | ₹18 Cr | — | — |

## Questions and answers

### What is the market cap of Adeshwar Medite?

Adeshwar Medite's market capitalisation is ₹21 Cr (₹21 Cr) at the 22 Oct 2026 close, ranking 3567th among the NSE companies Pivot tracks.

### What is the ROE and ROCE of Adeshwar Medite?

Return on equity was 5.6% in FY25 and return on capital employed was 10.5% in FY25 (standalone figures).

### Is Adeshwar Medite a debt-free company?

No. Adeshwar Medite's debt-to-equity ratio was 0.34 in FY25, with total debt of ₹2 Cr.

### What is the shareholding pattern of Adeshwar Medite?

As of 31 Mar 2026: promoters 57.68%, non-institutions 42.32%.

### Who are Adeshwar Medite's competitors?

The listed Pharma & Healthcare companies closest to Adeshwar Medite by market cap are Transgene Biote, Hamps Bio, Rekvina Labs, Maitri, Desh Rakshak and Nidan Lab.

### Is Adeshwar Medite a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Adeshwar Medite's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on ADESHWAR against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.